◆ TICKERBASEVue interactive →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

AccueilToutes les actions › ALGN · English version

Align Technology Inc (ALGN)

Historique du chiffre d'affaires, des bénéfices et des flux de trésorerie d'après les états financiers officiels.

Health Care · Wall Street (États-Unis) · Dernière mise à jour : 2026-09-19

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth.

Chiffres clés

Voir les graphiques interactifs et les états complets → Modèle de valorisation (DCF) →

Compte de résultat annuel

Compte de résultatTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Chiffre d'affaires total$4.1B$4.0B$4.0B$3.9B$3.7B$4.0B$2.5B$2.4B$2.0B$1.5B$1.1B$845M$762M$660M$560M$480M$387M$312M$304M$284M$206M
Bénéfice brut$2.8B$2.8B$2.8B$2.7B$2.6B$2.9B$1.8B$1.7B$1.4B$1.1B$815M$640M$578M$498M$416M$361M$303M$233M$225M$209M$142M
Marge brute %68.1%68.3%70.0%70.1%70.5%74.3%71.3%72.5%73.6%75.8%75.5%75.7%75.9%75.4%74.4%75.3%78.4%74.8%74.1%73.6%68.6%
Résultat opérationnel (EBIT)$622M$616M$608M$643M$643M$976M$387M$542M$467M$354M$249M$189M$194M$94M$86M$90M$103M($34M)$16M$34M($38M)
Marge opérationnelle %15.0%15.3%15.2%16.7%17.2%24.7%15.7%22.5%23.7%24.0%23.1%22.3%25.4%14.3%15.3%18.8%26.5%-10.9%5.1%11.9%-18.2%
Résultat net$414M$410M$421M$445M$362M$772M$1.8B$443M$400M$231M$190M$144M$146M$64M$59M$67M$74M($31M)$80M$36M($35M)
Marge nette %10.0%10.2%10.5%11.5%9.7%19.5%71.8%18.4%20.3%15.7%17.6%17.0%19.1%9.7%10.5%13.9%19.2%-10.0%26.3%12.6%-16.9%
EBITDA$766M$817M$643M$780M$1.1B$481M$593M$521M$391M$273M$207M$211M$178M$140M$108M$121M($21M)$30M$47M($27M)
Bénéfice par action (EPS)$5.75$5.65$5.62$5.81$4.61$9.69$22.41$5.53$4.92$2.83$2.33$1.77$1.77$0.78$0.71$0.83$0.95$-0.45$1.18$0.50$-0.55
Actions en circulation (M)73M75M77M78M80M79M80M81M82M81M82M82M83M83M80M78M69M68M71M63M

Source : rapports publics de la société (SEC). Vérifiez sur SEC EDGAR avant de vous fier à tout chiffre.

Bilans, flux de trésorerie, données trimestrielles et ratios complets dans le visualiseur interactif de ALGN. /companies/us/ALGN

Entreprises similaires

Les informations de ce site sont fournies à des fins éducatives et informatives uniquement ; elles ne constituent pas un conseil en investissement. Aucun objectif de cours ni recommandation n'est publié.

English version →Toutes les actions

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.